AMP.L Share News (AMP)

Amphion draws down on loan, notes possible Motif Bio IPO

(ShareCast News) - Medical, life science and technology business developer Amphion Innovations announced on Wednesday that it has agreed terms for the drawdown of an additional tranche of $0.75m under the loan facility first announced on 5 June 2014. The AIM-traded company said it will receive the p

WINNERS & LOSERS SUMMARY: Poundland Jumps On Steinhoff Takeover Deal

Motif Bio Shares Rise As It Files To List On NASDAQ Market (ALLIPO)

Amphion increases NAV through Motif Bio investment

(ShareCast News) - Medical and technology business developer Amphion Innovations announced its audited results for the 2015 calendar year on Thursday, in which it increased its net asset value per ordinary share in the company by 0.7p to 3.8p. The AIM-traded firm raised £2.1m during the period, thro

Amphion Reports Huge Net Asset Value Rise Thanks To Motif Bio

Amphion Innovations Agrees Additional Drawdown Of Loan (ALLISS)

Amphion Innovations To Draw Debt To Repay Existing Borrowings

Amphion Agrees USD1.6 Million Settlement Of Berkeley Research Dispute

Amphion Innovations buys itself time over promissory notes

(ShareCast News) - Amphion Innovations worked to assure investors on Tuesday it had bought itself some time over its promissory notes. The AIM-listed developer of medical and technology businesses reported on a meeting of the holders of the company's unsecured convertible promissory notes, which was

Amphion Convertible Promissory Notes, Macaleer Terms Extended (ALLISS)

Amphion Innovations To Draw Down Further Funds Under Loan Facility

Amphion Innovations announces m2m merger

(ShareCast News) - Amphion Innovations has signed a memorandum of understanding to merge its partner company m2m Imaging Corp with an undisclosed pulmonary imaging technology. Amphion, which develops medical, life science and technology businesses, said it expects to own around 40% of the combined m

Amphion Innovations Proposes Merging m2m With Imaging Company

Amphion Innovations Chairman Robert James Macaleer Dies

LONDON MARKET MIDDAY: US Shares Seen Higher With Jobs Data In Focus